Clinical trial

TEIPP Immunotherapy in Patients With NSCLC

NCT05898763

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2021-09-29

PhasePHASE1 / PHASE2

Study timeline

Study start (actual)2021-09-29Date precision: day

Registry last updated2024-11-07

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Non Small Cell Lung Cancerunresolved

Interventions

TEIPP24 (LRPAP7-30V-SLP vaccine in Montanide ISA-51)DRUG

Sponsors & collaborators

Erasmus Medical Centerlead sponsor

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT05898763 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.